메뉴 건너뛰기




Volumn 361, Issue 12, 2009, Pages 1139-1151

Dabigatran versus warfarin in patients with atrial fibrillation

(593)  Connolly, Stuart J a   Ezekowitz, Michael D b   Yusuf, Salim a   Eikelboom, John a   Oldgren, Jonas c   Parekh, Amit b   Pogue, Janice a   Reilly, Paul A d   Themeles, Ellison a   Varrone, Jeanne d   Wang, Susan d   Alings, Marco e   Xavier, Denis f   Zhu, Jun g   Diaz, Rafael h   Lewis, Basil S i   Darius, Harald j   Diener, Hans Christoph k   Joyner, Campbell D l   Wallentin, Lars c   more..


Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DABIGATRAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROTON PUMP INHIBITOR; QUINIDINE; WARFARIN; ANTICOAGULANT AGENT; BENZIMIDAZOLE DERIVATIVE; DABIGATRAN ETEXILATE; PRODRUG; PYRIDINE DERIVATIVE;

EID: 70349306707     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa0905561     Document Type: Article
Times cited : (9611)

References (17)
  • 1
    • 34347394385 scopus 로고    scopus 로고
    • Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
    • Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007;146:857-867
    • (2007) Ann Intern Med , vol.146 , pp. 857-867
    • Hart, R.G.1    Pearce, L.A.2    Aguilar, M.I.3
  • 2
    • 33746833635 scopus 로고    scopus 로고
    • ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation - Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Arial Fibrillation)
    • Erratum, J Am Coll Cardiol 2007;50:562
    • Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Arial Fibrillation). J Am Coll Cardiol 2006;48:854-906. [Erratum, J Am Coll Cardiol 2007;50:562.]
    • (2006) J Am Coll Cardiol , vol.48 , pp. 854-906
    • Fuster, V.1    Rydén, L.E.2    Cannom, D.S.3
  • 3
    • 33645826019 scopus 로고    scopus 로고
    • Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation
    • Birman-Deych E, Radford MJ, Nilasena DS, Gage BF. Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation. Stroke 2006;37:1070-1074
    • (2006) Stroke , vol.37 , pp. 1070-1074
    • Birman-Deych, E.1    Radford, M.J.2    Nilasena, D.S.3    Gage, B.F.4
  • 4
    • 34249715284 scopus 로고    scopus 로고
    • Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation
    • DOI 10.1161/CIRCULATIONAHA.106.653048, PII 0000301720070529000005
    • Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 2007;115:2689-2696 (Pubitemid 46842784)
    • (2007) Circulation , vol.115 , Issue.21 , pp. 2689-2696
    • Hylek, E.M.1    Evans-Molina, C.2    Shea, C.3    Henault, L.E.4    Regan, S.5
  • 5
    • 57149140461 scopus 로고    scopus 로고
    • Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range
    • Connolly SJ, Pogue J, Eikelboom J, et al. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range. Circulation 2008;118:2029-2037
    • (2008) Circulation , vol.118 , pp. 2029-2037
    • Connolly, S.J.1    Pogue, J.2    Eikelboom, J.3
  • 6
    • 41949116970 scopus 로고    scopus 로고
    • Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate
    • Stangier J. Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate. Clin Pharmacokinet 2008;47:285-295
    • (2008) Clin Pharmacokinet , vol.47 , pp. 285-295
    • Stangier, J.1
  • 9
    • 64349107688 scopus 로고    scopus 로고
    • Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran
    • Ezekowitz MD, Connolly SJ, Parekh A, et al. Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran. Am Heart J 2009;157:805-810
    • (2009) Am Heart J , vol.157 , pp. 805-810
    • Ezekowitz, M.D.1    Connolly, S.J.2    Parekh, A.3
  • 11
    • 0033527355 scopus 로고    scopus 로고
    • Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis
    • Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999;131:492-501. (Pubitemid 29482392)
    • (1999) Annals of Internal Medicine , vol.131 , Issue.7 , pp. 492-501
    • Hart, R.G.1    Benavente, O.2    McBride, R.3    Pearce, L.A.4
  • 13
    • 65649145705 scopus 로고    scopus 로고
    • Effect of clopidogrel added to aspirin in patients with atrial fibrillation
    • The ACTIVE Investigators
    • The ACTIVE Investigators. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med 2009;360:2066-2078
    • (2009) N Engl J Med , vol.360 , pp. 2066-2078
  • 14
    • 33744945247 scopus 로고    scopus 로고
    • Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): A randomised controlled trial
    • ACTIVE Writing Group of the ACTIVE Investigators
    • ACTIVE Writing Group of the ACTIVE Investigators. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet 2006;367:1903-1912
    • (2006) Lancet , vol.367 , pp. 1903-1912
  • 15
    • 40749160810 scopus 로고    scopus 로고
    • Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: A randomised, open-label, non-inferiority trial
    • Amadeus Investigators, Erratum, Lancet 2008;372:2022
    • Amadeus Investigators, Bousser MG, Bouthier J, et al. Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial. Lancet 2008;371:315-321 [Erratum, Lancet 2008;372:2022.]
    • (2008) Lancet , vol.371 , pp. 315-321
    • Bousser, M.G.1    Bouthier, J.2
  • 16
    • 33644974597 scopus 로고    scopus 로고
    • Stroke prevention using the oral direct thrombin inhibitor ximelagatran in patients with non-valvular atrial fibrillation: Pooled analysis from the SPORTIF III and V studies
    • Executive Steering Committee of the SPORTIFF III and V Investigators
    • Deiner HC, Executive Steering Committee of the SPORTIFF III and V Investigators. Stroke prevention using the oral direct thrombin inhibitor ximelagatran in patients with non-valvular atrial fibrillation: pooled analysis from the SPORTIF III and V studies. Cerebrovasc Dis 2006;21:279-293
    • (2006) Cerebrovasc Dis , vol.21 , pp. 279-293
    • Deiner, H.C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.